- Home
- MDT vs WELL Comparison
MDT vs WELL Comparison
Compare MDT & WELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDT
- WELL
- Stock Information
- Founded
- MDT 1949
- WELL 1970
- Country
- MDT Ireland
- WELL United States
- Employees
- MDT N/A
- WELL N/A
- Industry
- MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- WELL Real Estate Investment Trusts
- Sector
- MDT Health Care
- WELL Real Estate
- Exchange
- MDT Nasdaq
- WELL Nasdaq
- Market Cap
- MDT 112.3B
- WELL 103.4B
- IPO Year
- MDT N/A
- WELL N/A
- Fundamental
- Price
- MDT $92.97
- WELL $161.62
- Analyst Decision
- MDT Buy
- WELL Buy
- Analyst Count
- MDT 17
- WELL 10
- Target Price
- MDT $98.33
- WELL $164.70
- AVG Volume (30 Days)
- MDT 7.3M
- WELL 2.4M
- Earning Date
- MDT 08-19-2025
- WELL 07-28-2025
- Dividend Yield
- MDT 3.06%
- WELL 1.66%
- EPS Growth
- MDT 30.80
- WELL 111.52
- EPS
- MDT 3.61
- WELL 1.73
- Revenue
- MDT $33,537,000,000.00
- WELL $8,554,464,000.00
- Revenue This Year
- MDT $6.32
- WELL $25.89
- Revenue Next Year
- MDT $5.27
- WELL $12.06
- P/E Ratio
- MDT $25.74
- WELL $93.44
- Revenue Growth
- MDT 3.62
- WELL 24.49
- 52 Week Low
- MDT $78.32
- WELL $108.24
- 52 Week High
- MDT $96.25
- WELL $162.26
- Technical
- Relative Strength Index (RSI)
- MDT 75.40
- WELL 68.01
- Support Level
- MDT $89.18
- WELL $159.38
- Resistance Level
- MDT $92.77
- WELL $158.55
- Average True Range (ATR)
- MDT 1.55
- WELL 2.56
- MACD
- MDT 0.29
- WELL 0.59
- Stochastic Oscillator
- MDT 97.67
- WELL 94.54
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
About WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,336 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.